The first edition of the Joint “ESO-DFCI Breast Cancer in Young Women Symposium” will be held during the Breast Cancer: New Horizons, Current Controversies Course, on July 15 in Boston, United States.
Breast cancer in young women is a complex disease, occurring when these women are at the peak of their reproductive years, family life and careers. Being a somewhat rare disease the optimal management of these patients is based on scientific data derived from clinical trials mostly conducted on older women. Many aspects of breast cancer in young women are therefore poorly understood (e.g. etiology and biology among others) and research is much needed in this field. In addition, young women have many years ahead of them to suffer the long-term effects of treatment or the consequences of recurrent disease. The Joint ESO-DFCI Breast Cancer in Young Women Symposium is an opportunity for the latest updates on this field and a platform for generating future research concepts and collaborations covering topics on epidemiology, molecular biology, genetics, pathology, surgery, radiotherapy, systemic therapy, survivorship issues (e.g. fertility preservation, psychosocial needs) in young women with breast cancer.
Specific learners include breast cancer Medical Oncologists, Surgical Oncologists, Breast Surgeons, Radiation Oncologists, Registered Nurses, Nurse Practitioners, and other clinicians interested in the care of women and men with breast cancer.
The session will be held during the Breast Cancer: New Horizons, Current Controversies Course.
All the info are available in the website of ESO.